Mucins are high molecular weight glycoproteins which are heavily glycosylat
ed with many carbohydrate side chains. In epithelial cancers such as biliop
ancreatic cancer, both quantitative and qualitative alterations in carbohyd
rate and polypeptide moieties of mucin glycoproteins occur. These changes i
n mucin glycoproteins are one of the most common phenotypic markers of bili
opancreatic carcinogenesis and may play an important pathobiological role.
The expression of some of the sialylated carbohydrate antigens appears to c
orrelate with a poor prognosis and increased metastatic potential in biliop
ancreatic cancer. The increased exposure of peptide epitopes of mucin glyco
proteins in biliopancreatic cancer appears to be due to either abnormal gly
cosylation and/or altered levels of mucin gene transcription. In addition,
dysregulation of tissue specific mucin gene expression occurs in biliopancr
eatic cancer. This information is currently being exploited for further elu
cidation of the molecular mechanisms involved in carcinogenesis, tumor prog
ression and metastasis, and the development of novel methods of diagnosis a
nd therapy of biliopancreatic cancer.